AmCad BioMed Corporation

AmCad BioMed Corporationverified

4188.TWO

Price:

$15.3

Market Cap:

$968.99M

AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases, such as thyroid cancers, fatty liver, liver fibrosis, and obstructive sleep apnea. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-CA, a software device for analyzing digital cytological images; AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from ...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2013-12-26

Stock Exchange

TWO

Ticker

4188.TWO

The PE Ratio as of December 2025 (TTM) for AmCad BioMed Corporation (4188.TWO) is -20.13

According to AmCad BioMed Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -20.13. This represents a change of -24.12% compared to the average of -26.53 of the last 4 quarters.

AmCad BioMed Corporation (4188.TWO) Historical PE Ratio (quarterly & annually)

How has 4188.TWO PE Ratio performed in the past?

The mean historical PE Ratio of AmCad BioMed Corporation over the last ten years is -29.44. The current -20.13 PE Ratio has changed 6.74% with respect to the historical average. Over the past ten years (40 quarters), 4188.TWO's PE Ratio was at its highest in in the December 2022 quarter at -10.52. The PE Ratio was at its lowest in in the December 2024 quarter at -52.22.

Quarterly (TTM)
Annual

Average

-29.44

Median

-30.48

Minimum

-40.32

Maximum

-15.87

AmCad BioMed Corporation (4188.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of AmCad BioMed Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 101.63%

Maximum Annual PE Ratio = -15.87

Minimum Annual Increase = -60.63%

Minimum Annual PE Ratio = -40.32

Quarterly (TTM)
Annual
YearPE RatioChange
2024-25.50-20.31%
2023-32.00101.63%
2022-15.87-60.63%
2021-40.3239.24%
2020-28.95-14.77%

AmCad BioMed Corporation (4188.TWO) Average PE Ratio

How has 4188.TWO PE Ratio performed in the past?

The current PE Ratio of AmCad BioMed Corporation (4188.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-24.46

5-year avg

-28.53

10-year avg

-29.44

AmCad BioMed Corporation (4188.TWO) PE Ratio vs. Peers

How is 4188.TWO’s PE Ratio compared to its peers?

AmCad BioMed Corporation’s PE Ratio is less than PlexBio Co., Ltd. (-13.87), less than TFBS Bioscience Inc. (-12.62), greater than Puriblood Medical Co., Ltd. (-129.55), less than SynCore Biotechnology Co.,Ltd (-17.29), greater than NatureWise Biotech & Medicals Corporation (-25.98), less than Radiant Innovation Inc. (-14.49), greater than Eusol Biotech Co.,Ltd. (-22.12), less than Andros Pharmaceuticals Co.,Ltd (-12.15), less than LAUNXP Biomedical Co., Ltd (-6.52), less than General Biologicals Corporation (-2.92),

Build a custom stock screener for AmCad BioMed Corporation (4188.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AmCad BioMed Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AmCad BioMed Corporation (4188.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AmCad BioMed Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is AmCad BioMed Corporation's PE Ratio?

How is the PE Ratio calculated for AmCad BioMed Corporation (4188.TWO)?

What is the highest PE Ratio for AmCad BioMed Corporation (4188.TWO)?

What is the 3-year average PE Ratio for AmCad BioMed Corporation (4188.TWO)?

What is the 5-year average PE Ratio for AmCad BioMed Corporation (4188.TWO)?

How does the current PE Ratio for AmCad BioMed Corporation (4188.TWO) compare to its historical average?